Which stock wins in a matchup between these two successful biotechs?
These stocks have increased their dividends for 50-plus years. Here's why they should remain long-term winners.
A disruptive player in the orthodontics market competes against a newer disruptor that's now publicly traded. Should Align shareholders be worried?
Which stock wins in a battle between these pharmacy giants?
Hint: It's not the company's massive production capacity.
Which stock wins in a battle between a Canadian cannabis producer and a U.S. cannabis producer/retailer?
Which stock wins in a matchup between an up-and-coming biotech and a longtime biotech leader?
Which stock wins in a matchup between a leading U.S. cannabis retailer and an up-and-coming Canadian cannabis producer?
A positive outlook from an analyst lit a fire beneath the Canadian cannabis producer's shares.
Time to Hit the Panic Button With Aurora Cannabis? Why 1 Analyst Slashed His Price Target by Over 30%
Aurora's delayed pathway to profitability is causing some big problems.
And what they're likely to do with their billions of dollars that could richly reward investors.
Investors appear to be worried about potential safety issues with its cannabinoid gel.
Amgen's recent clinical setback just might prompt the big biotech to light a fire beneath its acquisition efforts.
These 2 Cannabis Companies Kicked In Over $1 Million to Legalize Pot in Florida. Will Their Bets Pay Off?
Sunny beaches, popular theme parks -- and recreational marijuana? Big bucks are flowing in to make legal pot in Florida a reality.
Hundreds of mysterious cases of vaping-related illnesses are causing some to advocate that legalizing pot is more important now than ever.
Great business models. Great growth prospects. Great moats. These three stocks check off all the boxes for buying and holding for years to come.
Which stock wins in a battle between these two continuous glucose monitoring system leaders?
Which stock wins in a matchup between a gene sequencing pioneer and a fast-rising liquid biopsy leader?
These cannabis stocks are profitable. They're growing rapidly. And they're great picks to buy right now.
Forget Aurora's revenue miss in Q4. Here's what investors need to be concerned about going forward.